Literature DB >> 4098045

Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial.

L J Booth, G M Aber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4098045     DOI： 10.1016/s0140-6736(70)92817-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  The morphological and clinical course of the different forms of glomerulonephritis.

Authors:  H Fishbach; A Bohle; D Meyer; H H Edel; U Frotscher; R Kluthe; D Renner; K Rinsche; F Scheler
Journal:  Klin Wochenschr       Date:  1976-02-01

2.  Treatment of active chronic hepatitis with cyclophosphamide.

Authors:  R Naccarato; R Farini; M Chiaramonte; U Fagiolo; G C Sturniolo
Journal:  Postgrad Med J       Date:  1974-01       Impact factor: 2.401

3.  Renal isotransplantation without immunosuppression.

Authors:  R Weil; T E Starzl; K A Porter; M Kershaw; G P Schröter; L J Koep
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

4.  Regional program for the study of glomerulonephritis. Central Committee of the Toronto Glomerulonephritis Registry.

Authors: 
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

5.  Effect of immunosuppression on chronic LCM virus infection of mice.

Authors:  P E Hoffsten; F J Dixon
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.